Patent classifications
C
C12
C12N
2770/00
C12N2770/00011
C12N2770/24011
C12N2770/24111
C12N2770/24161
C12N2770/24161
ATTENUATED VIRUSES USEFUL FOR VACCINES
20170067030
·
2017-03-09
·
This invention provides an attenuated virus which comprises a modified viral genome containing nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce synonymous deoptimized codons into the genome. The instant attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the instant attenuated virus. Further, this invention further provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of a vaccine composition comprising the instant attenuated virus.